ORIGINAL RESEARCH article
Front. Neurol.
Sec. Multiple Sclerosis and Neuroimmunology
Volume 16 - 2025 | doi: 10.3389/fneur.2025.1649998
From demyelination to neurodegeneration in multiple sclerosis: reassessing the role of Visual Evoked Potential P100-N145 amplitudes: a missing piece of the puzzle?
Provisionally accepted
Nurhan Kaya Tutar*
Nilufer Kale- Istanbul Bagcilar Egitim ve Arastirma Hastanesi, Istanbul, Türkiye
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Multiple sclerosis (MS) is a chronic demyelinating disease with a heterogeneous clinical course, making long-term disability prediction challenging. Visual evoked potentials (VEPs), particularly amplitude-based parameters, may serve as sensitive biomarkers of neurodegeneration and functional decline undetected by conventional clinical measures. Objective: To assess the relationship between longitudinal changes in P100–N145 amplitude and concurrent Expanded Disability Status Scale (EDSS) changes in relapsing-remitting MS (RRMS) and the relative utility of baseline and longitudinal VEP parameters in representing disability status. Methods: In this retrospective cohort study, 45 MS patients (90 eyes) with available VEP and EDSS data were followed for a median period of 48 months. The primary endpoints were (1) change in EDSS score over time and (2) EDSS progression, defined as any increase in EDSS score from baseline to follow-up. Generalized estimating equations (GEE) and logistic regression were used to investigate the relationships between the VEP parameters at baseline and follow-up and EDSS progression, accounting for inter-eye correlation; partial correlation analysis assessed amplitude–EDSS change associations, controlling for age. Results: EDSS progression was observed in 17.8% of patients. A longitudinal decrease in P100–N145 amplitude from baseline to follow-up was significantly associated with EDSS progression (OR: 1.511, 95% CI, p < 0.001). In addition, partial correlation analysis adjusting for age revealed a significant negative association between the difference in P100–N145 amplitude and EDSS difference (defined as baseline minus follow-up) in both eyes (right eye: r = –0.339, p = 0.024; left eye: r = –0.406, p = 0.006). In contrast, the changes in P100 latency and N75–P100 amplitude did not correlate significantly with EDSS worsening. Baseline VEP parameters, including P100 latency, N75–P100, and P100–N145 amplitudes, did not predict EDSS progression or change over time (all p > 0.05). Conclusion: Our results demonstrate that a reduction in P100–N145 amplitude over time is associated with worsening disability in RRMS. This suggests that the P100–N145 may be an underestimated marker of progressive functional deterioration in RRMS.
Keywords: Multiple Sclerosis, VEP, neurodegeneration, P100–N145, Disability progression, EDSS
Received: 19 Jun 2025; Accepted: 10 Sep 2025.
Copyright: © 2025 Kaya Tutar and Kale. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Nurhan Kaya Tutar, Istanbul Bagcilar Egitim ve Arastirma Hastanesi, Istanbul, Türkiye
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.